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Title: Deciphering the Mechanisms of AMPK Activation upon  
Anchorage-Deprivation 
 
AMP-activated protein kinase (AMPK) is a key regulator of energy homeostasis in cells. 
It has been implicated as a therapeutic target for various metabolic diseases like type II 
diabetes and obesity. However, its role in cancer is context-dependent and therefore 
warrants further studies to explore its possible use as a therapeutic target. AMPK can 
either promote or retard the growth of cancer cells depending on other cues and stresses 
in the milieu of the cancer cells. This study aims to understand AMPK signaling in 
response to extracellular cues of matrix deprivation and matrix stiffness that are important 
determinants of metastasis.  
 
1) Calcium-Oxidant Signaling Network Regulates AMPK Activation upon 
Matrix Deprivation. 
 
Recent work from our lab, as well as others, has identified a novel role for the cellular 
energy sensor AMP-activated protein kinase in epithelial cancer cell survival under 
matrix deprivation. However, the molecular mechanisms that activate AMPK upon 
matrix-detachment remain unexplored. In this study, we show that AMPK activation is a 
rapid and sustained phenomenon upon matrix deprivation, while re-attachment to the 
matrix leads to its dephosphorylation and inactivation. Since matrix-detachment leads to 
loss of integrin signaling, we investigate whether integrin signaling negatively regulates 
AMPK activation. However, modulation of FAK or Src, the major downstream 
components of integrin signaling, fails to cause a corresponding change in AMPK 
signaling. Further investigations reveal that the upstream AMPK kinases, LKB1 and 
CaMKKβ, contribute to AMPK activation upon detachment. Additionally, we show 
LKB1 phosphorylation and cytosolic translocation upon matrix deprivation, which might 
also contribute to AMPK activation. In LKB1-deficient cells, we find AMPK activation 
to be predominantly dependent on CaMKKβ. We observe no change in ATP levels under 
detached conditions at early time points suggesting that rapid AMPK activation upon 
detachment is not triggered by energy stress. We demonstrate that matrix deprivation 
leads to a spike in intracellular calcium as well as oxidant signaling and both these 
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intracellular messengers contribute to rapid AMPK activation upon detachment. We 
further show that ER calcium release induced store-operated calcium entry (SOCE) 
contributes to intracellular calcium increase, leading to ROS production, and AMPK 
activation. We additionally show that the LKB1/CaMKK-AMPK axis and intracellular 
calcium levels play a critical role in anchorage-independent cancer sphere formation. We 
find a significant increase in LKB1 as well as pACC levels in breast tumour tissues in 
comparison to normal tissues. Further, we observe a significant correlation between 
LKB1 and pACC levels in breast tumour tissues suggesting that LKB1-AMPK signaling 
pathway is active in vivo in breast cancers. Thus, the Ca2+/ROS triggered LKB1/CaMKK-
AMPK signaling cascade may provide a quick, adaptable switch to promote survival of 
metastasising cancer cells.  
2) Extracellular Matrix Stiffness Regulates Stemness through AMPK. 
 
Cancer cells experience changes in extracellular matrix stiffness during cancer 
progression. However, the signaling pathways utilised in sensing matrix stiffness are 
poorly understood. In this study, we identify AMPK pathway as a possible 
mechanosensory pathway in response to matrix stiffness. AMPK activity, as measured by 
downstream target phosphorylation, is found to be higher in soft matrix conditions. We 
additionally show that compared to stiff matrices, soft matrices increase stemness 
properties, as evidenced by the increased expression of stemness markers, which is 
dependent on AMPK activity. Thus, we elucidate a novel mechanotransduction pathway 
triggered by matrix stiffness that contributes to stemness of cancer cells by regulating 
AMPK activity.  
 
Taken together, our study identifies a novel calcium-oxidant signaling network in the 
rapid modulation of AMPK signaling in the context of matrix detachment. This pathway 
is especially relevant in the context of metastasising cancer cells that may not face energy 
stress in the blood stream but are matrix-deprived. Inhibition of AMPK might 
compromise the viability of these circulating cells thereby reducing the metastatic spread 
of cancer. Our study further suggests that varying stiffnesses experienced by cancer cells 
can modulate AMPK activity and this, in turn, regulates stem-like properties. Thus our 
study provides novel insights into various extracellular cues that regulate this kinase and 
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contribute to cell survival and metastasis. This knowledge can be utilised in the stage-
specific use of AMPK inhibitors in the treatment of breast cancer patients.  
 
